Cost-Effectiveness Analysis of Active Surveillance Compared to Early Surgery in Small Papillary Thyroid Cancer: A Systemic Review

References

• YiHS, ChangJY, KimKS, ShongM. Oncogenes, mitochondrial metabolism, and quality control in differentiated thyroid cancer. Korean J Intern Med. 2017;32(5):780–789. doi:10.3904/kjim.2016.42028823142
   PubMed Web of Science ®Google Scholar
• HongS, WonY-J, ParkYR, et al. Cancer statistics in Korea: incidence, mortality, survival, and prevalence in 2017. Cancer Res Treat. 2020;52(2):335–350. doi:10.4143/crt.2020.20632178489
   PubMed Web of Science ®Google Scholar
• DaviesL, WelchHG. Current thyroid cancer trends in the United States. JAMA Otolaryngol Head Neck Surg. 2014;140(4):317–322. doi:10.1001/jamaoto.2014.124557566
   PubMed Web of Science ®Google Scholar
• ItoY, MiyauchiA, KiharaM, HigashiyamaT, KobayashiK, MiyaA. Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation. Thyroid. 2014;24(1):27–34. doi:10.1089/thy.2013.036724001104
   PubMed Web of Science ®Google Scholar
• AhnHS, KimHJ, WelchHG. Korea’s thyroid-cancer “epidemic”–screening and overdiagnosis. N Engl J Med. 2014;371(19):1765–1767. doi:10.1056/NEJMp140984125372084
   PubMed Web of Science ®Google Scholar
• ChoSJ, SuhCH, BaekJH, et al. Active surveillance for small papillary thyroid cancer: a systematic review and meta-analysis. Thyroid. 2019;29(10):1399–1408. (1557–9077 (Electronic)). doi:10.1089/thy.2019.015931368412
   PubMed Web of Science ®Google Scholar
• KwonH, JeonMJ, KimWG, et al. A comparison of lobectomy and total thyroidectomy in patients with papillary thyroid microcarcinoma: a retrospective individual risk factor-matched cohort study. Eur J Endocrinol. 2017;176(4):371–378. (1479–683X (Electronic)). doi:10.1530/EJE-16-084528089996
   PubMed Web of Science ®Google Scholar
• GuptaN, VermaR, DhimanRK, RajsekharK, PrinjaS. Cost-effectiveness analysis and decision modelling: a tutorial for clinicians. J Clin Exp Hepatol. 2020;10(2):177–184. doi:10.1016/j.jceh.2019.11.00132189934
   PubMed Web of Science ®Google Scholar
• WhiteheadSJ, AliS. Health outcomes in economic evaluation: the QALY and utilities. Br Med Bull. 2010;96(1):5–21. (1471–8391 (Electronic)). doi:10.1093/bmb/ldq03321037243
   PubMed Web of Science ®Google Scholar
• BertramMY, LauerJA, De JoncheereK, et al. Cost-effectiveness thresholds: pros and cons. Bull World Health Organ. 2016;94(12):925–930. doi:10.2471/BLT.15.16441827994285
   PubMed Web of Science ®Google Scholar
• ChoiMJ, KangSO, OhJJ, ParkSB, KimMJ, CheongHJ. Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea. Hum Vaccin Immunother. 2018;14(8):1914–1922. doi:10.1080/21645515.2018.145660229953307
   PubMed Web of Science ®Google Scholar
• LeeD, ShinHY, ParkSM. Cost-effectiveness of antiviral prophylaxis during pregnancy for the prevention of perinatal hepatitis B infection in South Korea. Cost Eff Resour Alloc. 2018;16:6. doi:10.1186/s12962-018-0088-929467596
   PubMed Web of Science ®Google Scholar
• YunJW, ChoiMJ, ShinGS, et al. Cost-effectiveness of influenza vaccine strategies for the elderly in South Korea. PLoS One. 2019;14(1):e0209643. doi:10.1371/journal.pone.020964330682030
   PubMed Web of Science ®Google Scholar
• NeumannPJ, CohenJT, WeinsteinMC. Updating cost-effectiveness–the curious resilience of the $50,000-per-QALY threshold. N Engl J Med. 2014;371(9):796–797. doi:10.1056/NEJMp140515825162885
   PubMed Web of Science ®Google Scholar
• GarrisonLPJr, PaulyMV, WillkeRJ, NeumannPJ. An overview of value, perspective, and decision context-A health economics approach: an ISPOR special task force report [2]. Value Health. 2018;21(2):124–130. doi:10.1016/j.jval.2017.12.00629477389
   PubMed Web of Science ®Google Scholar
• BoccuzziSJ. Indirect health care costs. In: WeintraubWS, editor. Cardiovascular Health Care Economics. Contemporary Cardiology. Totowa, NJ: Humana Press; 2003. doi:10.1007/978-1-59259-398-9_5
   Google Scholar
• KuntzK, SainfortF, ButlerM, et al. Decision and Simulation Modeling in Systematic Reviews. Vol. 11. Rockville, MD: Agency for Healthcare Research and Quality; 2013.
   Google Scholar
• BoeckJD, VerpoortenK, LuytenK, ConinxK. A comparison between decision trees and markov models to support proactive interfaces. Paper presented at: 18th International Workshop on Database and Expert Systems Applications (DEXA 2007); September 3–7’ 2007; Regensburg.
   Google Scholar
• McCabeC, DixonS. Testing the validity of cost-effectiveness models. Pharmacoeconomics. 2000;17(5):501–513. doi:10.2165/00019053-200017050-0000710977390
   PubMed Web of Science ®Google Scholar
• ChiouCF, HayJW, WallaceJF, et al. Development and validation of a grading system for the quality of cost-effectiveness studies. Med Care. 2003;41(1):32–44. doi:10.1097/00005650-200301000-0000712544542
   PubMed Web of Science ®Google Scholar
• LangBHH, WongCKH. A cost-effectiveness comparison between early surgery and non-surgical approach for incidental papillary thyroid microcarcinoma. Eur J Endocrinol. 2015;173(3):367–375. doi:10.1530/EJE-15-045426104754
   PubMed Web of Science ®Google Scholar
• VenkateshS, PasternakJD, BeninatoT, et al. Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer. Surgery. 2017;161(1):116–126. doi:10.1016/j.surg.2016.06.07627839930
   PubMed Web of Science ®Google Scholar
• OdaH, MiyauchiA, ItoY, et al. Comparison of the costs of active surveillance and immediate surgery in the management of low-risk papillary microcarcinoma of the thyroid. Endocr J. 2017;64(1):59–64. doi:10.1507/endocrj.EJ16-038127667647
   PubMed Web of Science ®Google Scholar
• WhiteC, WeinsteinMC, FingeretAL, et al. Is less more? A microsimulation model comparing cost-effectiveness of the revised american thyroid association’s 2015 to 2009 guidelines for the management of patients with thyroid nodules and differentiated thyroid cancer. Ann Surg. 2020;271(4):765–773. doi:10.1097/SLA.000000000000307430339630
   PubMed Web of Science ®Google Scholar
• LubitzCC, De GregorioL, FingeretAL, et al. Measurement and variation in estimation of quality of life effects of patients undergoing treatment for papillary thyroid carcinoma. Thyroid. 2017;27(2):197–206. doi:10.1089/thy.2016.026027824301
   PubMed Web of Science ®Google Scholar
• LinJF, JonkerPKC, CunichM, et al. Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance. Surgery. 2020;167(1):110–116. doi:10.1016/j.surg.2019.05.07831543327
   PubMed Web of Science ®Google Scholar
• KimTY, ShongYK. Active surveillance of papillary thyroid microcarcinoma: a mini-review from Korea. Endocrinol Metab.2017;32(4):399–406. doi:10.3803/EnM.2017.32.4.399
   Web of Science ®Google Scholar
• LohiaS, HansonM, TuttleRM, MorrisLGT. Active surveillance for patients with very low-risk thyroid cancer. Laryngoscope Investig Otolaryngol. 2020;5(1):175–182. doi:10.1002/lio2.356
   PubMed Web of Science ®Google Scholar
• OhHS, HaJ, KimHI, et al. Active surveillance of low-risk papillary thyroid microcarcinoma: a Multi-Center Cohort Study in Korea. Thyroid. 2018;28(12):1587–1594. doi:10.1089/thy.2018.026330226447
   PubMed Web of Science ®Google Scholar
• JeonMJ, KangYE, MoonJH, et al. Protocol for a Korean Multicenter Prospective Cohort Study of Active Surveillance or Surgery (KoMPASS) in papillary thyroid microcarcinoma. Endocrinol Metab. 2021;36(2):359. (2093–5978 (Electronic)). doi:10.3803/EnM.2020.890
   Web of Science ®Google Scholar
• Health Insurance Review & Assessment Service (HIRA). 2011 Medical Economic Evaluation Guideline; 2016. Available from: http://www.hira.or.kr/cms/participation/05/07/__icsFiles/afieldfile/2013/04/01/3.pdf. Korean.
   Google Scholar